Ignite Creation Date:
2024-05-06 @ 1:43 AM
Last Modification Date:
2024-10-26 @ 11:09 AM
Study NCT ID:
NCT01888588
Status:
COMPLETED
Last Update Posted:
2014-07-15
First Post:
2013-03-18
Brief Title:
Risk of Uncomplicated Peptic Ulcer in the General Population
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Risk of Uncomplicated Peptic Ulcer in the General Population
Status:
COMPLETED
Status Verified Date:
2014-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The analyses are conducted in a previous population-based cohort study using The Health Improvement Network database in the UK Cai et al 2009The aims of the post hoc analyses are
To estimate the relative risk of uncomplicated symptomatic peptic ulcer UPU associated with use of low dose aspirin ASA and other anti-inflammatory drugs NSAIDs steroids in the general population To estimate the dose-response and duration-response associated with use of these drugs To estimate the relative risk of UPU associated with naivenon-naive use of low dose ASA in the general population To evaluate the effect of proton pump inhibitors PPI alone or in combination with anti-inflammatory drugs on the occurrence of UPU in the general population To investigate the management of low dose ASAoral antiplatelets after UPU
To estimate the relative risk of uncomplicated symptomatic peptic ulcer UPU associated with use of low dose aspirin ASA and other anti-inflammatory drugs NSAIDs steroids in the general population To estimate the dose-response and duration-response associated with use of these drugs To estimate the relative risk of UPU associated with naivenon-naive use of low dose ASA in the general population To evaluate the effect of proton pump inhibitors PPI alone or in combination with anti-inflammatory drugs on the occurrence of UPU in the general population To investigate the management of low dose ASAoral antiplatelets after UPU
Detailed Description:
Risk of uncomplicated peptic ulcer in the general population
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None